ORIGINAL RESEARCH article

Front. Immunol.

Sec. Primary Immunodeficiencies

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1620291

A Norwegian cohort with STAT1-related diseasefurther expanding the clinical phenotype

Provisionally accepted
Karen Helene Bronken  MartinsenKaren Helene Bronken Martinsen1,2*Torstein  ØverlandTorstein Øverland1Asbjørg  Stray-PedersenAsbjørg Stray-Pedersen3Tore  Gunnar AbrahamsenTore Gunnar Abrahamsen2Børre  FevangBørre Fevang2,4Hans Christian  Erichsen LandsverkHans Christian Erichsen Landsverk1,2
  • 1Division of pediatric and adolescent medicine, Oslo University Hospital, Oslo, Norway
  • 2Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
  • 3Norwegian National Unit for Newborn Screening, Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway
  • 4Section of Clinical Immunology and Infectious Diseases, Division of specialized medicine and surgery, Oslo University Hospital, Oslo, Norway

The final, formatted version of the article will be published soon.

Inborn errors of immunity (IEIs) caused by mutations in STAT1 are associated with a broad range of clinical manifestations, ranging from relatively mild to life-threatening. Our aim was to give a clinical and molecular description of a Norwegian cohort with STAT1-related disease.This is a descriptive epidemiological study.We present 23 patients with heterozygous STAT1 mutations, from 12 unrelated Norwegian families.Eighteen individuals had STAT1 gain-of-function (GOF) variants. Chronic mucocutaneous candidiasis (CMC) was the most common manifestation, observed in 94% of patients. Herpesviruses caused morbidity in one-third of patients, with severe complications such as varicella meningitis, varicella retinitis and ulcerative CMV esophagitis seen in 17%. Autoimmune hypertriglyceridemia with GPIHBP1 autoantibodies was diagnosed in one patient, adding a new entity to STAT1 GOF.Fifty percent of patients suffered chronic ophthalmologic manifestations. Severe gastrointestinal manifestations were observed in 22% of patients.Five of the 23 patients had STAT1 loss-of-function (LOF) variants. Mendelian susceptibility to mycobacterial disease (MSMD) was detected in three patients. Malignancy and autoimmunity were observed in two patients, both were heterozygous for the p.Ala246Thr variant, which is likely associated with a more complex phenotype. Significant viral infections were also observed. Presently, our cohort represents the largest nationwide study on STAT1-related disease.We report novel clinical manifestations in STAT1 GOF, and suggest that heterozygous STAT1 LOF might be a more complex condition than originally presumed.

Keywords: STAT1 GOF1, STAT1 LOF2, Chronic mucocutaeous candidiasis (CMC)3, Autoimmune hypertriglyceridemia4, malignancy5, ophthalmologic6

Received: 29 Apr 2025; Accepted: 02 Jun 2025.

Copyright: © 2025 Martinsen, Øverland, Stray-Pedersen, Abrahamsen, Fevang and Landsverk. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Karen Helene Bronken Martinsen, Division of pediatric and adolescent medicine, Oslo University Hospital, Oslo, Norway

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.